Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics

Matthew Z Guo1 Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

https://orcid.org/0000-0003-4741-7463

Kristen A Marrone1 Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

Alexander Spira1 Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA;2 Virginia Cancer Specialists Research Institute, Fairfax, VA, USA;3 US Oncology, The Woodlands, TX, USA

David M Waterhouse3 US Oncology, The Woodlands, TX, USA;4 Oncology Hematology Care, Cincinnati, OH, Usa

Susan C Scott1 Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USACorrespondence[email protected]

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics

Citations (4)

Articles from other publishers (4)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date